BREAKING NEWS: U.S. Regulators Clear Wegovy for Weight Loss Approval

U.S. regulators have approved a pill version of the blockbuster weight-loss drug Wegovy, the first daily oral medication to treat obesity. The U.S. Food and Drug Administration (FDA) gave the green light to the pill on December 23, 2025.

The approval comes as a major breakthrough in the fight against obesity, with 100 million people in the U.S. suffering from the chronic disease. The pill is expected to be available within weeks, according to company officials.

Wegovy pills work similarly to injectable versions of the drug, mimicking a natural hormone that controls appetite and feelings of fullness. This approval hands drugmaker Novo Nordisk an edge over rival Eli Lilly, which is still reviewing its oral drug, orforglipron.

The FDA's approval of Wegovy pills marks a significant milestone in the treatment of obesity, a condition that has seen a revolution in treatment globally and in the U.S. in recent years. The injectable versions of Wegovy and Lilly's Zepbound have been widely used to treat obesity.

This is a developing story, and we will provide updates as more information becomes available.